The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-27
DOI
10.1038/s41416-019-0655-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism
- (2017) Volker H. Haase Hemodialysis International
- Lipocalin-2 and iron trafficking in the tumor microenvironment
- (2017) Michaela Jung et al. PHARMACOLOGICAL RESEARCH
- Iron Handling in Tumor-Associated Macrophages—Is There a New Role for Lipocalin-2?
- (2017) Michaela Jung et al. Frontiers in Immunology
- Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment
- (2017) Christina Mertens et al. OncoImmunology
- Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis
- (2016) Bilge Ören et al. JOURNAL OF PATHOLOGY
- Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression
- (2016) Christina Mertens et al. PLoS One
- Lipocalin 2 from macrophages stimulated by tumor cell–derived sphingosine 1-phosphate promotes lymphangiogenesis and tumor metastasis
- (2016) Michaela Jung et al. Science Signaling
- Macrophage-derived Lipocalin-2 contributes to ischemic resistance mechanisms by protecting from renal injury
- (2016) Michaela Jung et al. Scientific Reports
- Lipocalin 2 from macrophages stimulated by tumor cell–derived sphingosine 1-phosphate promotes lymphangiogenesis and tumor metastasis
- (2016) Michaela Jung et al. Science Signaling
- Oncotargets in Different Renal Cancer Subtypes
- (2015) Holger Moch et al. CURRENT DRUG TARGETS
- Neutrophil Gelatinase Associated Lipocalin is an Independent Predictor of Poor Prognosis in Cases of Papillary Renal Cell Carcinoma
- (2015) Mingxin Zhang et al. JOURNAL OF UROLOGY
- Iron homeostasis in breast cancer
- (2014) Oriana Marques et al. CANCER LETTERS
- IRP2 Regulates Breast Tumor Growth
- (2013) Wei Wang et al. CANCER RESEARCH
- Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors
- (2013) ANGELINA DI CARLO Oncology Letters
- Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer
- (2012) Jiang Yang et al. FASEB JOURNAL
- Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics
- (2012) W. M. Linehan GENOME RESEARCH
- Infusion of IL-10–expressing cells protects against renal ischemia through induction of lipocalin-2
- (2012) Michaela Jung et al. KIDNEY INTERNATIONAL
- Interleukin-10-Induced Neutrophil Gelatinase-Associated Lipocalin Production in Macrophages with Consequences for Tumor Growth
- (2012) M. Jung et al. MOLECULAR AND CELLULAR BIOLOGY
- Sensitivity and Specificity of Urinary Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 for the Diagnosis of Renal Cell Carcinoma
- (2011) Jeremiah J. Morrissey et al. AMERICAN JOURNAL OF NEPHROLOGY
- An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer
- (2011) L. D. Miller et al. CANCER RESEARCH
- Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma
- (2011) Tsutomu Miyamoto et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Sphingosine-1-phosphate signalling induces the production of Lcn-2 by macrophages to promote kidney regeneration
- (2011) Anna Sola et al. JOURNAL OF PATHOLOGY
- The Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney Injury
- (2011) Michael Haase et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Ngal reporter mouse detects the response of the kidney to injury in real time
- (2011) Neal Paragas et al. NATURE MEDICINE
- La neutrophil gelatinase-associated lipocalin, ou LCN 2, facteur d’agressivité dans le carcinome rénal à cellules claires (CRCC)
- (2011) C. Perrin et al. PROGRES EN UROLOGIE
- Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib
- (2010) Camillo Porta et al. KIDNEY INTERNATIONAL
- Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: Correlation with histotype and histological grade
- (2010) Barresi ONCOLOGY REPORTS
- Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis
- (2010) T. Berger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
- (2009) Hany Onsy Habashy et al. BREAST CANCER RESEARCH AND TREATMENT
- The Role of Electrostatics in Siderophore Recognition by the Immunoprotein Siderocalin1
- (2008) Trisha M. Hoette et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation